BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CoEHAR - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:CoEHAR
X-ORIGINAL-URL:https://www.coehar.org
X-WR-CALDESC:Events for CoEHAR
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Rome
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20241027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230919
DTEND;VALUE=DATE:20230920
DTSTAMP:20260424T003525
CREATED:20230905T182421Z
LAST-MODIFIED:20230905T182458Z
UID:12613-1695081600-1695167999@www.coehar.org
SUMMARY:Between risk\, prevention\, diagnosis\, and therapies for dyslipidemias
DESCRIPTION:High cholesterol is one of the leading risk factors for cardiovascular disease\, as evidenced by multiple epidemiological and intervention studies that have shown a near-linear relationship between this dyslipidemia\, morbidity\, and cardiovascular mortality. \nAfter the forced break due to the SARS-CoV-2 pandemic\, it is appropriate to return to discussing “non-communicable chronic diseases” whose health risks have continued to accumulate in the last 3 years. \nThe conference aims to bring attention to the diagnosis and management of hypercholesterolemia in light of the latest guidelines produced by the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). \nInnovative topics such as environmental risk factors\, including smoking and their role in the progression of atherosclerosis\, will be addressed. Diagnostic ultrasound for patients with hypercholesterolemia (with a particular focus on carotid Doppler) and innovative pharmacological approaches that include PCSK9 inhibitors and bempedoic acid\, drugs that have made new intervention possibilities possible in patients at high and very high cardiovascular risk\, will be discussed. Hypercholesterolemia familial\, a hereditary disease in which a genetic alteration causes extremely high levels of LDL cholesterol that correlate with the high risk of cardiac events in carriers\, will also be discussed. \nThe final session proposes non-pharmacological suggestions for the management of cardiovascular risk\, including lifestyle\, physical activity\, nutraceuticals\, and nutrition\, and in particular\, the Mediterranean diet as a lifestyle that originates in our territory that should be adopted and exported\, physical activity that brings us back in contact with the environment and also has an ecological meaning\, and the potential role of nutraceuticals.
URL:https://www.coehar.org/event/between-risk-prevention-diagnosis-and-therapies-for-dyslipidemias/
LOCATION:Bari\, Bari\, Italy
ATTACH;FMTTYPE=image/webp:https://www.coehar.org/wp-content/uploads/2023/09/Schermata-2023-09-05-alle-11.24.51.png.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230921
DTEND;VALUE=DATE:20230924
DTSTAMP:20260424T003525
CREATED:20230208T160527Z
LAST-MODIFIED:20230208T160527Z
UID:11064-1695254400-1695513599@www.coehar.org
SUMMARY:Toxi 2023
DESCRIPTION:Dear Colleagues\, \nIt is a great pleasure to announce that The Scientistt will host the 2nd Global Summit on Toxicology and Applied Pharmacology (TOXI2023)will be held in Lisbon\, Portugal during September 21-23\, 2023 \nTOXI2023 aims to bring together the renowned researchers\, scientists and scholars to exchange ideas\, to present sophisticated research works and to discuss hot topics in the field and share their experiences on all aspects of Toxicology and Applied Pharmacology. \nThe TOXI2023 will be a 3 days event that means to gather the key players of the Biomaterials and Applications community and related sectors. This event is launched with the aims to become an established event\, attracting global participants\, intent on sharing\, exchanging and exploring new avenues of Toxicology and Applied Pharmacology. \nA wide-ranging scientific program consisting of plenary lectures\, keynote lectures\, Invited lectures\, parallel sessions\, as well as poster sessions for young scientists covering all topics in Biomaterials and Applications will be scheduled. This conference provides a wonderful opportunity for you to enhance your knowledge about the newest interdisciplinary approaches in Toxicology and Applied Pharmacology. \nMoreover\, the conference offers a valuable platform to create new contacts in the field of Toxicology and Applied Pharmacology. By  providing valuable networking time for you to meet great personnel in the field. \nWe look forward to seeing you at TOXI2023 in Lisbon\, Portugal.
URL:https://www.coehar.org/event/toxi-2023/
LOCATION:Lisbona\, Lisbona\, Portugal
ATTACH;FMTTYPE=image/jpeg:https://www.coehar.org/wp-content/uploads/2023/02/602-banners-Photo.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230925
DTEND;VALUE=DATE:20230927
DTSTAMP:20260424T003525
CREATED:20230321T155300Z
LAST-MODIFIED:20230321T155300Z
UID:11298-1695600000-1695772799@www.coehar.org
SUMMARY:6th Scientific Summit on Tobacco Harm Reduction: Novel products\, Research & Policy
DESCRIPTION:The 6th Scientific Summit on Tobacco Harm Reduction: Novel products\, Research & Policy will be held on the 25th & 26th September 2023 in Athens. Mark the new venue at the city center\, the Royal Olympic Hotel. \nA call for Abstracts will be launched shortly\, inviting researchers to present on: \nToxicology and aerosol chemistry – Chemical composition of the aerosol\, droplet size and distribution\, temperature and toxicants\, indoor air quality | Biomarkers’ evaluation in animal or human studies | Preclinical evaluation Epidemiology & Social Issues (Perception risk\, Attractiveness etc.) | Clinical Assessment and Harm Reduction | Regulatory issues | Bioethics | Innovation & Novel Products | Smoking cessation | Educational issues in adolescence.
URL:https://www.coehar.org/event/6th-scientific-summit-on-tobacco-harm-reduction-novel-products-research-policy/
LOCATION:Athene\, Athene\, Greece
ATTACH;FMTTYPE=image/jpeg:https://www.coehar.org/wp-content/uploads/2023/03/650x400px_6th-Summit_SAVEtheDATE_F.jpg
END:VEVENT
END:VCALENDAR